These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8638530)

  • 1. Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p'DDD. Clinical case reports.
    Zidan J; Shpendler M; Robinson E
    Am J Clin Oncol; 1996 Jun; 19(3):229-31. PubMed ID: 8638530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16).
    Johnson DH; Greco FA
    Cancer; 1986 Nov; 58(10):2198-202. PubMed ID: 3756767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study.
    Bukowski RM; Wolfe M; Levine HS; Crawford DE; Stephens RL; Gaynor E; Harker WG
    J Clin Oncol; 1993 Jan; 11(1):161-5. PubMed ID: 8418229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
    Hermsen IG; Fassnacht M; Terzolo M; Houterman S; den Hartigh J; Leboulleux S; Daffara F; Berruti A; Chadarevian R; Schlumberger M; Allolio B; Haak HR; Baudin E
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1844-51. PubMed ID: 21470991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.
    Schlumberger M; Brugieres L; Gicquel C; Travagli JP; Droz JP; Parmentier C
    Cancer; 1991 Jun; 67(12):2997-3000. PubMed ID: 2044046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.
    Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L
    J Endocrinol Invest; 2006 Jun; 29(6):560-2. PubMed ID: 16840836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical use of o,p'DDD in adrenocortical carcinoma].
    Bacchetta J; Droz JP
    Bull Cancer; 2005 Mar; 92(3):273-9. PubMed ID: 15820922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.
    Bonacci R; Gigliotti A; Baudin E; Wion-Barbot N; Emy P; Bonnay M; Cailleux AF; Nakib I; Schlumberger M;
    Br J Cancer; 1998 Aug; 78(4):546-9. PubMed ID: 9716042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
    Burgess MA
    Minerva Endocrinol; 1995 Mar; 20(1):101-4. PubMed ID: 7651278
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant mitotane for adrenocortical cancer--a recurring controversy.
    Huang H; Fojo T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3730-2. PubMed ID: 18842984
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic microsomal enzyme induction and adrenal crisis due to o,p'DDD therapy for metastatic adrenocortical carcinoma.
    Hague RV; May W; Cullen DR
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):51-7. PubMed ID: 2574647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
    Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
    Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.
    Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L
    Endocr Relat Cancer; 2005 Sep; 12(3):657-66. PubMed ID: 16172198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.
    Berruti A; Terzolo M; Paccotti P; Veglio F; Pia A; Dogliotti L; Angeli A
    Tumori; 1992 Oct; 78(5):345-8. PubMed ID: 1494808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].
    Ueda S; Nakane K; Namiki S; Takeuchi Y; Kawase M; Takeuchi S; Kawase K; Nakai C; Kato D; Takai M; Iinuma K; Tsuchiya T; Miyazaki T; Koie T
    Hinyokika Kiyo; 2022 May; 68(5):139-143. PubMed ID: 35748231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.
    Baudin E; Pellegriti G; Bonnay M; Penfornis A; Laplanche A; Vassal G; Schlumberger M
    Cancer; 2001 Sep; 92(6):1385-92. PubMed ID: 11745214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.